| ’÷Ø |
Šz |
‘ÎÛ |
‰ž•å—ð |
Ì‘ð—ð |
||
| ‰ÈŒ¤”ï |
“Á•ÊŒ¤‹†ˆõDC2 |
‹‹—¿20–œ‰~ x 24‚©ŒŽ Œ¤‹†”ï150–œ‰~ x 2”N |
”ŽŽm‰Û’ö3”N¶ˆÈã ƒoƒCƒg•s‰Â |
|||
| ŽáŽèŒ¤‹†(B) | ŠwˆÊŽæ“¾Œã |
2010-2011”N“x 2016-2017”N“x |
||||
| Šî”ÕŒ¤‹†(C) |
2018-2020”N“x 2021/4-2024/3 2024/4-2027/3 |
|||||
| •¬‹à |
“ú–{“œ”A•aŠw‰ï@ŽáŽèŒ¤‹†•¬‹à |
3ŒŽ |
100–œ‰~ x 2”N |
41Ζ¢–žB‘åŠw‰@¶‚à‰ÂB“¯ˆêuÀ‚©‚ç1–¼BYIA‚Æ“¯Žž‰ž•å‰Â |
||
| G-7Œ¤‹†ŠJ”•¬ |
300–œ‰~ | 2020/3-2021/4 2023/4-2024/3 2024/4-2025/3 2025/4-2026/3 |
||||
| PRiME |
25–œ‰~ |
2025/4-2026/3 2026/4-2027/3 |
||||
| —é–Ø–œ•½“œ”A•aà’c@ŽáŽèŒ¤‹†’²¸Œ¤‹†•¬ | 9/30 | 200–œ‰~ | 2023/4-2025/3 | |||
| —é–Ø–œ•½“œ”A•aà’c@’²¸Œ¤‹†•¬B |
250–œ‰~ x 3”N |
2025/4-2028/3 |
||||
| “ú–{”ì–žŠw‰ïEƒmƒ{ƒmƒ‹ƒfƒBƒXƒNƒtƒ@[ƒ}Œ¤‹†•¬ |
100–œ‰~ |
2024/1-2024/12 |
||||
| ¬–ìˆãŠwŒ¤‹†•¬ |
300–œ‰~ |
2024/4-2025/3 |
||||
| Front Runner of Future Diabetes Research | 2014-2020”N | |||||
| ‹»˜a¶–½‰ÈŠwU‹»à’cŒ¤‹†•¬ | 100–œ‰~ |
40Ζ¢–ž |
2020”N“x |
|||
| MSD¶–½‰ÈŠwà’cŒ¤‹†•¬@¶ŠˆKе•a—̈æ@ŽáŽèŒ¤‹†ŽÒ | 100–œ‰~ x 2”N | 42Έȉº | 2021/1-2022/12 | |||
| “à“¡‹L”O‰ÈŠw§—ã‹àEŒ¤‹†•¬ | 4/28 (Šw“à’÷Ø) |
|||||
| Ž“c‹L”OˆãŠw–òŠwU‹»à’c@Œ¤‹†•¬‹à | 5/6 |
|||||
| ƒAƒXƒeƒ‰ƒX•a‘Ô‘ãŽÓŒ¤‹†‰ïŒ¤‹†•¬ | 5/31 | |||||
| ‘æˆêŽO‹¤¶–½‰ÈŠwŒ¤‹†U‹»à’c@Œ¤‹†•¬ | 6/30 (Šw“à’÷Ø) |
|||||
| ƒx[ƒŠƒ“ƒK[/ƒŠƒŠ[“œ”A•aŒ¤‹†•¬ | ||||||
| MSD§ŠwŠñ•t | ||||||
| “ú–{“à•ª”åŠw‰ïŒ¤‹†•¬ | ||||||
| “à“¡‹L”O‰ÈŠw§—ã‹àEŽáŽèƒXƒeƒbƒvƒAƒbƒvŒ¤‹†•¬ | ‰ß‹Ž‚Ì“à“¡‹L”O‰ÈŠw§—ã‹àEŒ¤‹†•¬‚ÌŽó—ÌŽÒ | |||||
| ‘æˆêŽO‹¤§ŠwŠñ•tƒvƒƒOƒ‰ƒ€ | ||||||
| “c•ÓŽO•H»–òДޮ‰ïŽÐŒ¤‹†Žx‰‡ |